Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

Posts by ICR Westwicke

Westwicke Logo

Westwicke Partners is the largest healthcare focused investor relations firm in the country. We provide customized investor relations programs and independent capital markets advice to small and mid-cap healthcare companies.

2022 Trends: How COVID Is Changing the Healthcare Landscape

Posted on January 12th, 2022. Posted by

Old woman with face mask getting vaccinated, coronavirus, covid-19 and vaccination concept.

The COVID-19 pandemic continues to drive significant changes to nearly every industry, from real estate to staffing to consumer goods — but it fundamentally changed how consumers view and access healthcare. As the U.S. continues to navigate the pandemic, alongside mixed economic data, supply chain challenges, and labor challenges, what lies ahead for the healthcare industry in 2022? Below, our experts offer their predictions.  

Continue Reading

What the COVID-19 Pandemic Taught Us About the Power of Words

Posted on November 18th, 2021. Posted by

doctor giving patient vaccine

As public health officials discuss whether to call subsequent COVID-19 vaccinations “boosters,” fearing it gives the impression that previous inoculations weren’t effective—some preferred “third dose” or “final dose”—chalk it up to yet another debate about words and nomenclature related to the worst global pandemic in a century.

Continue Reading

The Current and Future State of Biotech Financing

Posted on November 1st, 2021. Posted by

In the face of a global pandemic, capital markets have (understandably) seen unprecedented behavior over the past two years. With vaccines, rapid testing, and medical research at center stage of every news outlet and publication, the biotech sector has been especially active. There have been major shifts in both buy- and sell-side activities, leaving many companies wondering how to best raise capital as the world finds its new normal. As young and emerging biotech companies look forward, there is growing concern about the current and future state of funding.

Continue Reading

Beyond Bullet Points: 4 Design Tips to Make a Memorable Investor Presentation

Posted on October 2nd, 2019. Posted by

Memorable Investor Presentations

Creating a presentation for an audience of investors is a balancing act. On the one hand, there are specific pieces of information that investors want to see in a certain way, and if you don’t provide that information, they’ll wonder what you’re trying to hide. On the other hand, investors see so many presentations every month — hundreds of slides, thousands of charts, and an endless barrage of bullets and sub-bullets — it’s no wonder that so few make a lasting impression.

Continue Reading

Clinical trial data disclosure can be tricky.

Download our checklist of 10 disclosure guidelines to minimize risk and maximize the impact of good news.

Download Now

Our Locations